Medical and Pharmaceutical Sana Biotechnology could offer relief to diabetes type 1 sufferers in the future The study showed that Sana's hypoimmune (HIP) modified pancreatic islet cells could successfully evade the patient's immune system Joseph MortonJanuary 9, 2025